Click for best price
Endothelin Antagonist Therapy Market Size, Share 2024
The global Endothelin Antagonist Therapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Endothelin Antagonist Therapy include Gilead Sciences, Sun Pharmaceutical Industries, Lupin, Zydus Group, Endo International, Mylan N.V, Teva Pharmaceutical Industries, Sigmapharm Laboratories and Alembic Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Endothelin Antagonist Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endothelin Antagonist Therapy. This report contains market size and forecasts of Endothelin Antagonist Therapy in global, including the following market information:
Global Endothelin Antagonist Therapy Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Endothelin Antagonist Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endothelin Antagonist Therapy Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Endothelin Antagonist Therapy Market Segment Percentages, by Type, 2023 (%)
Oral
Parenteral
Global Endothelin Antagonist Therapy Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Endothelin Antagonist Therapy Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Diagnostic Centers
Others
Global Endothelin Antagonist Therapy Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Endothelin Antagonist Therapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endothelin Antagonist Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Endothelin Antagonist Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Sun Pharmaceutical Industries
Lupin
Zydus Group
Endo International
Mylan N.V
Teva Pharmaceutical Industries
Sigmapharm Laboratories
Alembic Pharmaceuticals
Hikma Pharmaceuticals
Amneal Pharmaceuticals
AstraZeneca
Johnsons & Johnsons Private limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Endothelin Antagonist Therapy, market overview.
Chapter 2: Global Endothelin Antagonist Therapy market size in revenue.
Chapter 3: Detailed analysis of Endothelin Antagonist Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endothelin Antagonist Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Endothelin Antagonist Therapy Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Endothelin Antagonist Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endothelin Antagonist Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endothelin Antagonist Therapy Overall Market Size
2.1 Global Endothelin Antagonist Therapy Market Size: 2023 VS 2030
2.2 Global Endothelin Antagonist Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Endothelin Antagonist Therapy Players in Global Market
3.2 Top Global Endothelin Antagonist Therapy Companies Ranked by Revenue
3.3 Global Endothelin Antagonist Therapy Revenue by Companies
3.4 Top 3 and Top 5 Endothelin Antagonist Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Endothelin Antagonist Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endothelin Antagonist Therapy Players in Global Market
3.6.1 List of Global Tier 1 Endothelin Antagonist Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Endothelin Antagonist Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Endothelin Antagonist Therapy Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Endothelin Antagonist Therapy Revenue & Forecasts
4.2.1 By Type - Global Endothelin Antagonist Therapy Revenue, 2019-2024
4.2.2 By Type - Global Endothelin Antagonist Therapy Revenue, 2025-2030
4.2.3 By Type - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endothelin Antagonist Therapy Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Endothelin Antagonist Therapy Revenue & Forecasts
5.2.1 By Application - Global Endothelin Antagonist Therapy Revenue, 2019-2024
5.2.2 By Application - Global Endothelin Antagonist Therapy Revenue, 2025-2030
5.2.3 By Application - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Endothelin Antagonist Therapy Market Size, 2023 & 2030
6.2 By Region - Global Endothelin Antagonist Therapy Revenue & Forecasts
6.2.1 By Region - Global Endothelin Antagonist Therapy Revenue, 2019-2024
6.2.2 By Region - Global Endothelin Antagonist Therapy Revenue, 2025-2030
6.2.3 By Region - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Endothelin Antagonist Therapy Revenue, 2019-2030
6.3.2 US Endothelin Antagonist Therapy Market Size, 2019-2030
6.3.3 Canada Endothelin Antagonist Therapy Market Size, 2019-2030
6.3.4 Mexico Endothelin Antagonist Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Endothelin Antagonist Therapy Revenue, 2019-2030
6.4.2 Germany Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.3 France Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.4 U.K. Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.5 Italy Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.6 Russia Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.8 Benelux Endothelin Antagonist Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Endothelin Antagonist Therapy Revenue, 2019-2030
6.5.2 China Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.3 Japan Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.4 South Korea Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.6 India Endothelin Antagonist Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Endothelin Antagonist Therapy Revenue, 2019-2030
6.6.2 Brazil Endothelin Antagonist Therapy Market Size, 2019-2030
6.6.3 Argentina Endothelin Antagonist Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Endothelin Antagonist Therapy Revenue, 2019-2030
6.7.2 Turkey Endothelin Antagonist Therapy Market Size, 2019-2030
6.7.3 Israel Endothelin Antagonist Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Endothelin Antagonist Therapy Market Size, 2019-2030
6.7.5 UAE Endothelin Antagonist Therapy Market Size, 2019-2030
7 Endothelin Antagonist Therapy Companies Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Endothelin Antagonist Therapy Major Product Offerings
7.1.4 Gilead Sciences Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 Sun Pharmaceutical Industries
7.2.1 Sun Pharmaceutical Industries Company Summary
7.2.2 Sun Pharmaceutical Industries Business Overview
7.2.3 Sun Pharmaceutical Industries Endothelin Antagonist Therapy Major Product Offerings
7.2.4 Sun Pharmaceutical Industries Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.2.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.3 Lupin
7.3.1 Lupin Company Summary
7.3.2 Lupin Business Overview
7.3.3 Lupin Endothelin Antagonist Therapy Major Product Offerings
7.3.4 Lupin Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.3.5 Lupin Key News & Latest Developments
7.4 Zydus Group
7.4.1 Zydus Group Company Summary
7.4.2 Zydus Group Business Overview
7.4.3 Zydus Group Endothelin Antagonist Therapy Major Product Offerings
7.4.4 Zydus Group Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.4.5 Zydus Group Key News & Latest Developments
7.5 Endo International
7.5.1 Endo International Company Summary
7.5.2 Endo International Business Overview
7.5.3 Endo International Endothelin Antagonist Therapy Major Product Offerings
7.5.4 Endo International Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.5.5 Endo International Key News & Latest Developments
7.6 Mylan N.V
7.6.1 Mylan N.V Company Summary
7.6.2 Mylan N.V Business Overview
7.6.3 Mylan N.V Endothelin Antagonist Therapy Major Product Offerings
7.6.4 Mylan N.V Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.6.5 Mylan N.V Key News & Latest Developments
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Company Summary
7.7.2 Teva Pharmaceutical Industries Business Overview
7.7.3 Teva Pharmaceutical Industries Endothelin Antagonist Therapy Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.7.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.8 Sigmapharm Laboratories
7.8.1 Sigmapharm Laboratories Company Summary
7.8.2 Sigmapharm Laboratories Business Overview
7.8.3 Sigmapharm Laboratories Endothelin Antagonist Therapy Major Product Offerings
7.8.4 Sigmapharm Laboratories Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.8.5 Sigmapharm Laboratories Key News & Latest Developments
7.9 Alembic Pharmaceuticals
7.9.1 Alembic Pharmaceuticals Company Summary
7.9.2 Alembic Pharmaceuticals Business Overview
7.9.3 Alembic Pharmaceuticals Endothelin Antagonist Therapy Major Product Offerings
7.9.4 Alembic Pharmaceuticals Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.9.5 Alembic Pharmaceuticals Key News & Latest Developments
7.10 Hikma Pharmaceuticals
7.10.1 Hikma Pharmaceuticals Company Summary
7.10.2 Hikma Pharmaceuticals Business Overview
7.10.3 Hikma Pharmaceuticals Endothelin Antagonist Therapy Major Product Offerings
7.10.4 Hikma Pharmaceuticals Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.10.5 Hikma Pharmaceuticals Key News & Latest Developments
7.11 Amneal Pharmaceuticals
7.11.1 Amneal Pharmaceuticals Company Summary
7.11.2 Amneal Pharmaceuticals Business Overview
7.11.3 Amneal Pharmaceuticals Endothelin Antagonist Therapy Major Product Offerings
7.11.4 Amneal Pharmaceuticals Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.11.5 Amneal Pharmaceuticals Key News & Latest Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Company Summary
7.12.2 AstraZeneca Business Overview
7.12.3 AstraZeneca Endothelin Antagonist Therapy Major Product Offerings
7.12.4 AstraZeneca Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.12.5 AstraZeneca Key News & Latest Developments
7.13 Johnsons & Johnsons Private limited
7.13.1 Johnsons & Johnsons Private limited Company Summary
7.13.2 Johnsons & Johnsons Private limited Business Overview
7.13.3 Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Major Product Offerings
7.13.4 Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.13.5 Johnsons & Johnsons Private limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Endothelin Antagonist Therapy Market Opportunities & Trends in Global Market
Table 2. Endothelin Antagonist Therapy Market Drivers in Global Market
Table 3. Endothelin Antagonist Therapy Market Restraints in Global Market
Table 4. Key Players of Endothelin Antagonist Therapy in Global Market
Table 5. Top Endothelin Antagonist Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Endothelin Antagonist Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Endothelin Antagonist Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Endothelin Antagonist Therapy Product Type
Table 9. List of Global Tier 1 Endothelin Antagonist Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endothelin Antagonist Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Endothelin Antagonist Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Endothelin Antagonist Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Endothelin Antagonist Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Endothelin Antagonist Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Endothelin Antagonist Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Endothelin Antagonist Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Endothelin Antagonist Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Endothelin Antagonist Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Endothelin Antagonist Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Endothelin Antagonist Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Endothelin Antagonist Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Endothelin Antagonist Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Endothelin Antagonist Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Endothelin Antagonist Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Gilead Sciences Company Summary
Table 31. Gilead Sciences Endothelin Antagonist Therapy Product Offerings
Table 32. Gilead Sciences Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Gilead Sciences Key News & Latest Developments
Table 34. Sun Pharmaceutical Industries Company Summary
Table 35. Sun Pharmaceutical Industries Endothelin Antagonist Therapy Product Offerings
Table 36. Sun Pharmaceutical Industries Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Sun Pharmaceutical Industries Key News & Latest Developments
Table 38. Lupin Company Summary
Table 39. Lupin Endothelin Antagonist Therapy Product Offerings
Table 40. Lupin Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Lupin Key News & Latest Developments
Table 42. Zydus Group Company Summary
Table 43. Zydus Group Endothelin Antagonist Therapy Product Offerings
Table 44. Zydus Group Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Zydus Group Key News & Latest Developments
Table 46. Endo International Company Summary
Table 47. Endo International Endothelin Antagonist Therapy Product Offerings
Table 48. Endo International Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Endo International Key News & Latest Developments
Table 50. Mylan N.V Company Summary
Table 51. Mylan N.V Endothelin Antagonist Therapy Product Offerings
Table 52. Mylan N.V Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. Mylan N.V Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Company Summary
Table 55. Teva Pharmaceutical Industries Endothelin Antagonist Therapy Product Offerings
Table 56. Teva Pharmaceutical Industries Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Teva Pharmaceutical Industries Key News & Latest Developments
Table 58. Sigmapharm Laboratories Company Summary
Table 59. Sigmapharm Laboratories Endothelin Antagonist Therapy Product Offerings
Table 60. Sigmapharm Laboratories Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Sigmapharm Laboratories Key News & Latest Developments
Table 62. Alembic Pharmaceuticals Company Summary
Table 63. Alembic Pharmaceuticals Endothelin Antagonist Therapy Product Offerings
Table 64. Alembic Pharmaceuticals Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Alembic Pharmaceuticals Key News & Latest Developments
Table 66. Hikma Pharmaceuticals Company Summary
Table 67. Hikma Pharmaceuticals Endothelin Antagonist Therapy Product Offerings
Table 68. Hikma Pharmaceuticals Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. Hikma Pharmaceuticals Key News & Latest Developments
Table 70. Amneal Pharmaceuticals Company Summary
Table 71. Amneal Pharmaceuticals Endothelin Antagonist Therapy Product Offerings
Table 72. Amneal Pharmaceuticals Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. Amneal Pharmaceuticals Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Endothelin Antagonist Therapy Product Offerings
Table 76. AstraZeneca Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Johnsons & Johnsons Private limited Company Summary
Table 79. Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Product Offerings
Table 80. Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. Johnsons & Johnsons Private limited Key News & Latest Developments
List of Figures
Figure 1. Endothelin Antagonist Therapy Segment by Type in 2023
Figure 2. Endothelin Antagonist Therapy Segment by Application in 2023
Figure 3. Global Endothelin Antagonist Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Endothelin Antagonist Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Endothelin Antagonist Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Endothelin Antagonist Therapy Revenue in 2023
Figure 8. By Type - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global Endothelin Antagonist Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global Endothelin Antagonist Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 16. US Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 20. Germany Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 28. China Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Endothelin Antagonist Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Gilead Sciences Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Sun Pharmaceutical Industries Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Lupin Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Zydus Group Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Endo International Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Mylan N.V Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Teva Pharmaceutical Industries Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Sigmapharm Laboratories Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Alembic Pharmaceuticals Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Hikma Pharmaceuticals Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Amneal Pharmaceuticals Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. AstraZeneca Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
